BARCELONA, Spain–(BUSINESS WIRE)–Ferrer and Prilenia Announce Authorization for EU Initiation of Confirmatory PRECISE-HD Study of Pridopidine in Huntington’s Disease.
BARCELONA, Spain–(BUSINESS WIRE)–Ferrer and Prilenia Announce Authorization for EU Initiation of Confirmatory PRECISE-HD Study of Pridopidine in Huntington’s Disease.